DoD Tuberous Sclerosis Complex, Clinical Translational Research Award - 0 views
-
MiamiOH OARS on 21 Feb 19The Clinical Translational Research Award supports studies that will move promising, well-founded preClinical and/or Clinical research findings closer to Clinical application, including diagnosis, prognosis, or treatment of TSC. Projects supported by this award mechanism may include studies moving from preClinical to Clinical research (including a pilot Clinical trial) and/or the reverse, analyzing human anatomical substances and/or data associated with Clinical trials (such as correlative studies). Studies advancing Clinical trial readiness through development of biomarkers, Clinical endpoints, and validation of PK/PD are of particular interest to the FY19 TSCRP. Preference will be given to studies that involve human samples, patients, or leverage existing Clinical data and/or ongoing Clinical studies. PreClinical studies may be appropriate but must include a Clinical component. Projects that are exploratory and/or strictly animal research will not be considered for funding. Developmental pathways for translational research that may be useful for designing translational research studies for support under this mechanism can be found in the report of the National Cancer Institute Translational Research Working Group (http://clincancerres.aacrjournals.org/ content/14/18/5664.full). These pathways are comprehensive and span the entire translational research continuum from bench to bedside to bench.